|
⚲
|
| Keyboard |
| Lota Zoth | |
|---|---|
| Firm | |
| Address | 660 W Germantown Pike Suite 110 Plymouth Meeting, PA 19462 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals Inc | 021-358860 | Director | 4.0 M of 4.0 M |
||
| Inovio Pharmaceuticals Inc | 021-346682 | Director | 15.2 M of 15.2 M |
||
| Orexigen Therapeutics Inc | 021-281701 | Director | 49.6 M of 49.6 M |
||
| Orexigen Therapeutics Inc | 021-260134 | Director | 165.0 M of 330.0 M |
||
| Orexigen Therapeutics Inc | 021-247655 | Director | 60.0 M of 90.0 M |
||
| Hyperion Therapeutics Inc | 021-219438 | Director | 8.0 M of 8.0 M |
||
| Hyperion Therapeutics Inc | 021-168227 | Director | 7.5 M of 15.0 M |
||
| Hyperion Therapeutics Inc | 021-158551 | Director | 17.5 M of 35.0 M |
||
| Ikaria Holdings Inc | 021-102325 | Director | 54.9 M | ||
| Hyperion Therapeutics Inc | 021-99184 | Director | 22.0 M of 45.5 M |
||